146 related articles for article (PubMed ID: 30946310)
1. A research on the protein expression of p53, p16, and MDM2 in endometriosis.
Sang L; Fang QJ; Zhao XB
Medicine (Baltimore); 2019 Apr; 98(14):e14776. PubMed ID: 30946310
[TBL] [Abstract][Full Text] [Related]
2. p27kip1 overexpression regulates VEGF expression, cell proliferation and apoptosis in cell culture from eutopic endometrium of women with endometriosis.
Gonçalves GA; Camargo-Kosugi CM; Bonetti TC; Invitti AL; Girão MJ; Silva ID; Schor E
Apoptosis; 2015 Mar; 20(3):327-35. PubMed ID: 25534318
[TBL] [Abstract][Full Text] [Related]
3. p16INK4a hypermethylation and p53, p16 and MDM2 protein expression in esophageal squamous cell carcinoma.
Taghavi N; Biramijamal F; Sotoudeh M; Khademi H; Malekzadeh R; Moaven O; Memar B; A'rabi A; Abbaszadegan MR
BMC Cancer; 2010 Apr; 10():138. PubMed ID: 20388212
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of p53, MDM2, and p21Waf1 oncoproteins in endometriomas but not adenomyosis.
Goumenou A; Panayiotides I; Mahutte NG; Matalliotakis I; Fragouli Y; Arici A
J Soc Gynecol Investig; 2005 May; 12(4):263-6. PubMed ID: 15866118
[TBL] [Abstract][Full Text] [Related]
5. P53 gene mutation and expression of MDM2, P53, P16 protein and their relationship in human glioma.
Cui W; Wu R; Cao H; Gao J; Wang X; Ren Q
J Huazhong Univ Sci Technolog Med Sci; 2005; 25(6):622-4, 635. PubMed ID: 16696307
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of the p53, mdm2, p21/Waf-1, Rb, p16, Ki67, cyclin D1, cyclin A and cyclin B1 proteins and apoptotic index in T-cell lymphomas.
Kanavaros P; Bai M; Stefanaki K; Poussias G; Rontogianni D; Zioga E; Gorgoulis V; Agnantis NJ
Histol Histopathol; 2001 Apr; 16(2):377-86. PubMed ID: 11332692
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis and bcl-2 expression in normal human endometrium, endometriosis and adenomyosis.
Jones RK; Searle RF; Bulmer JN
Hum Reprod; 1998 Dec; 13(12):3496-502. PubMed ID: 9886539
[TBL] [Abstract][Full Text] [Related]
8. Expression of apoptosis-related proteins in peritoneal, ovarian and colorectal endometriosis.
Dufournet C; Uzan C; Fauvet R; Cortez A; Siffroi JP; Daraï E
J Reprod Immunol; 2006 Jun; 70(1-2):151-62. PubMed ID: 16378643
[TBL] [Abstract][Full Text] [Related]
9. The co-expression of GPER and Gankyrin in ovarian endometriosis and its correlation with the rASRM stages.
Zhang C; Yuan X; Zhang Y
Arch Gynecol Obstet; 2016 Jan; 293(1):133-141. PubMed ID: 26193952
[TBL] [Abstract][Full Text] [Related]
10. Aberrations of the p53 pathway components p53, MDM2 and CDKN2A appear independent in diffuse large B cell lymphoma.
Møller MB; Ino Y; Gerdes AM; Skjødt K; Louis DN; Pedersen NT
Leukemia; 1999 Mar; 13(3):453-9. PubMed ID: 10086736
[TBL] [Abstract][Full Text] [Related]
11. Functional interaction between S100A1 and MDM2 may modulate p53 signaling in normal and malignant endometrial cells.
Nakagawa M; Higuchi S; Hashimura M; Oguri Y; Matsumoto T; Yokoi A; Ishibashi Y; Ito T; Saegusa M
BMC Cancer; 2022 Feb; 22(1):184. PubMed ID: 35177036
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical inactivation of p14ARF concomitant with MDM2 overexpression inversely correlates with p53 overexpression in oral squamous cell carcinoma.
Sano T; Hikino T; Xue Q; Saito T; Kashiwabara K; Oyama T; Nakajima T
Pathol Int; 2000 Sep; 50(9):709-16. PubMed ID: 11012984
[TBL] [Abstract][Full Text] [Related]
13. Anti-apoptotic and pro-apoptotic gene expression evaluated from eutopic endometrium in the proliferative phase of the menstrual cycle among women with endometriosis and healthy controls.
Zubor P; Hatok J; Galo S; Dokus K; Klobusiakova D; Danko J; Racay P
Eur J Obstet Gynecol Reprod Biol; 2009 Aug; 145(2):172-6. PubMed ID: 19467764
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of MDM2, p16, and p53 staining levels as biomarkers of biochemical recurrence following salvage radiation therapy for recurrent prostate cancer.
Heckman MG; Parker AS; Wu KJ; Hilton TW; Ko SJ; Pisansky TM; Schild SE; Khor LY; Hammond EH; Pollack A; Buskirk SJ
Prostate; 2012 Dec; 72(16):1757-66. PubMed ID: 22513981
[TBL] [Abstract][Full Text] [Related]
15. p16 Controls p53 Protein Expression Through miR-dependent Destabilization of MDM2.
Al-Khalaf HH; Aboussekhra A
Mol Cancer Res; 2018 Aug; 16(8):1299-1308. PubMed ID: 29739873
[TBL] [Abstract][Full Text] [Related]
16. Normal human mammary epithelial cells proliferate rapidly in the presence of elevated levels of the tumor suppressors p53 and p21(WAF1/CIP1).
Huschtscha LI; Moore JD; Noble JR; Campbell HG; Royds JA; Braithwaite AW; Reddel RR
J Cell Sci; 2009 Aug; 122(Pt 16):2989-95. PubMed ID: 19638413
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of pRb, p16, p14ARF, MDM2, p21 and p53 in squamous cell carcinomas of lung.
Xue Q; Sano T; Kashiwabara K; Oyama T; Nakajima T
Jpn J Cancer Res; 2001 Mar; 92(3):285-92. PubMed ID: 11267938
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of Mdm2, p53 and p16 in patients with astrocytomas.
Ranuncolo SM; Varela M; Morandi A; Lastiri J; Christiansen S; Bal de Kier Joffé E; Pallotta MG; Puricelli L
J Neurooncol; 2004 Jun; 68(2):113-21. PubMed ID: 15218947
[TBL] [Abstract][Full Text] [Related]
19. ELF4/MEF activates MDM2 expression and blocks oncogene-induced p16 activation to promote transformation.
Sashida G; Liu Y; Elf S; Miyata Y; Ohyashiki K; Izumi M; Menendez S; Nimer SD
Mol Cell Biol; 2009 Jul; 29(13):3687-99. PubMed ID: 19380490
[TBL] [Abstract][Full Text] [Related]
20. MDM2 controls the timely expression of cyclin A to regulate the cell cycle.
Frum R; Ramamoorthy M; Mohanraj L; Deb S; Deb SP
Mol Cancer Res; 2009 Aug; 7(8):1253-67. PubMed ID: 19671680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
